Stellar Biotechnologies, Inc. (Stellar), is engaged in production of purified Keyhole Limpet Hemocyanin (KLH) for use in a new class of medicines known as therapeutic vaccines and in immunological research. The Company is the only company dedicated solely to developing and commercializing KLH products. KLH is a component for cancer vaccines and anticipated therapeutic vaccines, including those for lymphoma, sarcoma, small cell lung cancer, Alzheimer�s disease, rheumatoid arthritis, lupus, and Post Traumatic Stress Disorder chemical dependencies. The Company provides cGMP KLH products to the biopharmaceutical and vaccine development markets. The Company's products include: stellar KLH protein and stellar KLH ELISA Kits.